Lung cancer in young patients

Area of Science:

• Oncology
• Thoracic Surgery
• Epidemiology

Background:

• Lung cancer is increasingly common, yet diagnoses in patients under 40 remain infrequent, representing a small fraction of overall cases.
• In Italy, 2.8% of lung cancer cases in 1992 were diagnosed in individuals younger than 40.
• This study focuses on a cohort of young lung cancer patients to understand their specific characteristics and outcomes.

Purpose of the Study:

• To analyze the clinical and pathological features of lung cancer in patients under 40 years of age.
• To compare the survival rates and prognostic factors in young lung cancer patients with those in older populations.
• To identify key factors influencing survival in this specific patient group.

Main Methods:

• A retrospective review of 800 patients with histologically confirmed lung cancer undergoing long-term follow-up.
• Analysis of a subgroup of 23 patients aged under 40.
• Univariate analysis to determine prognostic factors impacting survival.

Main Results:

• Young patients (under 40) represented 2.9% of the study cohort, with a male-to-female ratio of 1.87:1. Fifty-two percent were smokers, and 82.6% presented with symptoms at diagnosis.
• Adenocarcinoma and large-cell lung cancer types showed better 10-year survival (28.5%) compared to epidermoid and small-cell types.
• Tumor resectability was a critical factor, with curative resection in seven cases leading to a 44.4% 10-year survival rate, significantly better than non-resected patients. Stage I-II disease had an 80% 10-year survival rate.

Conclusions:

• Lung cancer in young patients exhibits similar clinical and pathological distributions and survival probabilities to older patients.
• Tumor resectability emerged as the sole independent favorable prognostic factor for survival in this young cohort.
• Early-stage diagnosis and surgical intervention are crucial for improving outcomes in young individuals diagnosed with lung cancer.